castlemans disease
May 12, 2014
Drug Trial for Castleman’s Gets Amazing Results
Carl Guenther was once told he had two years left to live. But a new drug treatment study led by UAMS has stretched that once-grim allotment into nine years and counting.
January 19, 2012
UAMS Names van Rhee First Scharlau Chair Recipient
Jan. 19, 2011 | Internationally known multiple myeloma researcher Frits van Rhee, M.D., Ph.D., was invested Jan. 17 as the inaugural recipient of the Charles & Clydene Scharlau Chair for Hematological Malignancies Research.